• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Thermo Fisher Scientific

Thermo Fisher Scientific

Thermo Fisher Scientific Inc TMO 2 Star

Last Price$125.64Day Change (%)0.62%
Open Price$124.56Day Change ($)0.77
Day Range123.27–125.7752-Week Range107.33–131.12

As of Mon 01/26/2015 05:19 PM EST | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Research and Markets: Global Transfection Technologies Market 2015-2019 with Bio-Rad Laboratories, Maxcyte, Polyplus Transfection, Promega & Thermo Fisher Scientific Dominating

    Research and Markets: Global Transfection Technologies Market 2015-2019 with Bio-Rad Laboratories, Maxcyte, Polyplus Transfection, Promega & Thermo Fisher Scientific Dominating

  2. These unloved stocks may beat the S&P 500 again in 2015

    These unloved stocks may beat the S&P 500 again in 2015

  3. Research and Markets: Global Infectious Disease Diagnostics Market 2014-2019 - Product, Application, Technology & End User Analysis of the $18 Billion Industry

    Research and Markets: Global Infectious Disease Diagnostics Market 2014-2019 - Product, Application, Technology & End User Analysis of the $18 Billion Industry

  4. Research and Markets: Digital PCR Market Research Report - 2014-2020 Global Industry Analysis

    Research and Markets: Digital PCR Market Research Report - 2014-2020 Global Industry Analysis

  5. Leader in Genomic Sequencing Illuminates the Way

    Continued technology advancements and market expansion support Illumina's narrow moat.

  6. Top 10 Buys and Sells by the Ultimate Stock-Pickers

    A group of top managers continue to keep looking for good investment opportunities, while taking full advantage of a rising (and potentially overvalued) market to book some gains.

  7. 10 High-Conviction Purchases by the Ultimate Stock-Pickers

    Top managers continue to exercise a lot of patience as they look for buying opportunities in a U.S. equity market that has risen close to 40% since the start of 2013.

  8. DNAe Acquires nanoMR Inc. in a Strategic Move to Own Complete Workflow for Point-Of-Need NGS-Based Blood-To-Result Diagnostic

    DNAe Acquires nanoMR Inc. in a Strategic Move to Own Complete Workflow for Point-Of-Need NGS-Based Blood-To-Result Diagnostic

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.